1215 related articles for article (PubMed ID: 26967232)
1. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
Kusendová K; Gavorník P; Sabaka P; Sviteková K
Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
[TBL] [Abstract][Full Text] [Related]
2. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
Nübling CM; Chudy M; Volkers P; Löwer J
Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
[TBL] [Abstract][Full Text] [Related]
3. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
[TBL] [Abstract][Full Text] [Related]
4. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.
Hitzler WE; Runkel S
Transfusion; 2001 Mar; 41(3):333-7. PubMed ID: 11274586
[TBL] [Abstract][Full Text] [Related]
5. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of serologic markers for hepatitis B and C viruses in Brazilian blood donors and incidence and residual risk of transfusion transmission of hepatitis C virus.
de Almeida-Neto C; Sabino EC; Liu J; Blatyta PF; Mendrone-Junior A; Salles NA; Leão SC; Wright DJ; Basques FV; Ferreira JE; Busch MP; Murphy EL;
Transfusion; 2013 Apr; 53(4):827-34. PubMed ID: 22882510
[TBL] [Abstract][Full Text] [Related]
7. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study.
Busch MP; Korelitz JJ; Kleinman SH; Lee SR; AuBuchon JP; Schreiber GB
Transfusion; 1995; 35(11):903-10. PubMed ID: 8604486
[TBL] [Abstract][Full Text] [Related]
8. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection.
Bhattacharya P; Chandra PK; Datta S; Banerjee A; Chakraborty S; Rajendran K; Basu SK; Bhattacharya SK; Chakravarty R
World J Gastroenterol; 2007 Jul; 13(27):3730-3. PubMed ID: 17659734
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Occult Hepatitis C Virus Infection among Blood Donors in Jiangsu, China.
Lin H; Chen X; Zhu S; Mao P; Zhu S; Liu Y; Huang C; Sun J; Zhu J
Intervirology; 2016; 59(4):204-210. PubMed ID: 28208127
[TBL] [Abstract][Full Text] [Related]
10. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
[TBL] [Abstract][Full Text] [Related]
11. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors.
Muselmani W; Habbal W; Monem F
Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787
[TBL] [Abstract][Full Text] [Related]
12. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008-2015).
Fiedler SA; Oberle D; Chudy M; Scheiblauer H; Henseler O; Halbauer J; Heiden M; Funk M
Vox Sang; 2019 Jul; 114(5):443-450. PubMed ID: 31012114
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B and C infection: is it a problem in Polish healthcare workers?
Rybacki M; Piekarska A; Wiszniewska M; Walusiak-Skorupa J
Int J Occup Med Environ Health; 2013 Jun; 26(3):430-9. PubMed ID: 23817869
[TBL] [Abstract][Full Text] [Related]
15. U.K. multicentre study on blood donors for surrogate markers of non-A non-B hepatitis. Part I: Alanine transferase and anti-HBc testing.
Anderson NA; Raafat A; Shwe KH; Barbara J; Contreras M; Fraser ID; Gunson HH; Martlew V; Mijovic V; Goldíe DJ
Transfus Med; 1992 Dec; 2(4):301-10. PubMed ID: 1285043
[TBL] [Abstract][Full Text] [Related]
16. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
[TBL] [Abstract][Full Text] [Related]
17. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
Chung HT; Lee JS; Lok AS
Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
[TBL] [Abstract][Full Text] [Related]
18. Blood test strategy of blood donors, ALT and HBsAg HCV-Ab correlation study.
Zheng L; Li X
Minerva Med; 2019 Feb; 110(1):18-26. PubMed ID: 30458610
[TBL] [Abstract][Full Text] [Related]
19. Serum alanine aminotransferase level in relation to hepatitis B and C virus infections among blood donors.
Tsai JF; Jeng JE; Ho MS; Wang CS; Chang WY; Hsieh MY; Lin ZY; Tsai JH
Liver; 1997 Feb; 17(1):24-9. PubMed ID: 9062876
[TBL] [Abstract][Full Text] [Related]
20. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
